ReportsnReports Adds Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
GBI Research, the leading business intelligence provider, has released its latest report, “Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market” which provides key data, information and analysis of the major trends and issues affecting the clinical trial market in Brazil.
View full press release